Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2026-06-16 16:46:48 ET · period of report 2026-06-12 · accession 0001376043-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-16 16:46 | 2026-06-12 | TVTX | Coughlin Timothy | Dir | M - OptEx | $26.52 | +10.0K | 66.2K | +18% | +$265.2K |
| DT | 2026-06-16 16:46 | 2026-06-12 | TVTX | Coughlin Timothy | Dir | S - Sale+OE | $50.07 | -10.0K | 56.2K | -15% | -$500.7K |
| DT | 2026-06-16 16:46 | 2026-06-12 | TVTX | Coughlin Timothy | Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-12 | M | A | 10,000 | $26.52 | 66,250 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-12 | S | D | 10,000 | $50.07 | 56,250 | D | — | — | (F1) This sale was made pursuant to a written plan adopted on November 19, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. (F2) The weighted average sale price for the transaction reported was $50.0747, and the range of prices were between $50.00 and $50.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-12 | M | D | 10,000 | $0.00 | 0 | D | $26.52 · — to 2028-05-08 | 10,000 Common Stock | (F3) The stock option is fully vested and exercisable. |